Legal Affairs
The Hemp Surge: A Growing Challenge to Regulated Cannabis
NEW YORK — The legal line between hemp and cannabis ...
Navigating Local Cannabis Regulations: A State-by-State Guide
NEW YORK — Cannabis regulation in the United States functions ...
The Role of Government Relations in Cannabis Industry Success
NEW YORK — In highly regulated industries, success depends not ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
Why Bob Hoban Is Defending Steve DeAngelo—And What It Reveals About Cannabis Policy
LOS ANGELES- In cannabis industry discourse, facts can be overshadowed by simplified narratives. One such claim—widely circulated in trade circles—is that Steve DeAngelo, founder of Harborside and a prominent figure in the legalization movement, was ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
Why Bob Hoban Is Defending Steve DeAngelo—And What It Reveals About Cannabis Policy
LOS ANGELES- In cannabis industry discourse, facts can be overshadowed by simplified narratives. One such claim—widely circulated in trade circles—is that Steve DeAngelo, founder of Harborside and a prominent figure in the legalization movement, was ...
DEA Grants Import Permit for Psilocybin Truffles to Red Light Holland and Irvine Labs
LOS ANGELES- Red Light Holland Corp, an Ontario-based producer of psilocybin truffles, announced that its U.S. partner, Irvine Labs, has received a Controlled Substances Import Permit from the Drug Enforcement Administration (DEA). This authorization allows ...
Glass House Brands Proposes Long-Term Incentive Plan Tied to Share Price Performance
LOS ANGELES- Glass House Brands Inc. a vertically integrated cannabis company, has announced the mailing of its management information circular to shareholders ahead of its annual and special meeting scheduled for June 20, 2025. At ...
Minnesota Legislature Advances Cannabis Market Framework to Governor
LOS ANGELES- Minnesota lawmakers have passed a comprehensive bill aimed at refining the state's adult-use cannabis program, forwarding it to Governor Tim Walz for approval. The legislation, known as SF 2370, seeks to address regulatory ...
Cannabis in Psychedelic Therapy: Potential and Precautions
LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...
Cybin Partners with Thermo Fisher for U.S. Manufacturing
LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...
Rubicon Organics Appoints Glen Ibbott as Interim CFO
LOS ANGELES- Rubicon Organics Inc. a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin ...
TILT Holdings Reports First Quarter 2025 Financial Results
LOS ANGELES- TILT Holdings Inc. announced its financial results for the first quarter ended March 31, 2025, reflecting a year-over-year revenue decline and continued strategic realignment towards its Jupiter inhalation technology business. Financial Performance The ...
High-Paying Roles in the Cannabis Industry
LOS ANGELES- As the cannabis industry continues its expansion across the United States, it presents a variety of high-paying career opportunities. Positions such as cultivation directors, compliance officers, and extraction technicians are in demand, offering ...
German Medical Cannabis Market Sees Significant Growth
LOS ANGELES- Germany's medical cannabis industry is experiencing substantial growth, driven by recent regulatory reforms and increasing patient demand. Companies such as Cantourage are at the forefront of this expansion, capitalizing on the evolving legal ...
Canopy Growth Introduces Targeted Product Expansion for Canadian Market
LOS ANGELES- Canopy Growth Corporation has announced a strategic expansion of its product portfolio, focusing on four high-demand segments within Canada's adult-use cannabis market: vapes, high-THC flower, pre-rolls, and edibles. This initiative is part of ...
U.S. Legal Cannabis Sales Surpass $30 Billion in 2024
LOS ANGELES- In 2024, legal cannabis sales in the United States reached $30.1 billion, marking a 4.5% increase from the previous year. This growth occurred despite a 3.4% reduction in industry employment, equating to approximately ...
iAnthus Capital Holdings Reports Q1 2025 Financial Results
LOS ANGELES- iAnthus Capital Holdings, Inc. a multi-state operator in the U.S. regulated cannabis industry, released its financial results for the first quarter ended March 31, 2025. Financial Highlights Revenue: $38.1 million, a decrease from ...
Silo Pharma Initiates Safety Study for PTSD Drug SPC-15
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...
Glass House Brands to Manage The Leaf El Paseo Dispensary
LOS ANGELES- Glass House Brands Inc. and LEEF Brands Inc. have entered into a Management Services Agreement (MSA), under which Glass House will oversee operations of The Leaf El Paseo dispensary in Palm Desert, California. ...
Pennsylvania Senate Committee Rejects Cannabis Legalization Bill
LOS ANGELES- In a recent development, the Pennsylvania Senate Law and Justice Committee voted 7-3 against House Bill 1200, a proposal aimed at legalizing adult-use cannabis in the state. This decision follows the bill's narrow ...
Humboldt Family Farms: The Science of Natural Light
In the lush tapestry of cannabis cultivation, the sun shines like a master artist, painting each plant with strokes of light that define its essence. The embrace of natural sunlight not only stimulates the growth ...
atai Life Sciences Initiates Phase 2 Trial of EMP-01 for Social Anxiety Disorder
LOS ANGELES- atai Life Sciences has commenced a Phase 2 clinical trial evaluating EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine (R-MDMA), for the treatment of social anxiety disorder (SAD). The first patient has been dosed in ...
Village Farms International Reports Q1 2025
LOS ANGELES- Village Farms International Inc. has announced its financial results for the first quarter of 2025, highlighting a strategic pivot towards its cannabis operations and the privatization of certain fresh produce assets. For the ...
Legalization Significantly Reduces Canada’s Illicit Cannabis Market
LOS ANGELES- Recent analyses indicate that Canada's legalization of non-medical cannabis in 2018 has substantially shifted consumer spending from illicit to legal markets. Studies report that within five years of legalization, approximately 75% of cannabis ...
New York Cannabis Policy Faces Criticism Amid Regulatory Challenges
LOS ANGELES- Boris Jordan, CEO of Curaleaf Holdings Inc., a multi-state cannabis operator, has publicly criticized New York Governor Kathy Hochul and state cannabis regulators, alleging that current policies are detrimental to established medical cannabis ...
Cybin Secures Additional U.S. Patent for CYB003
LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...
